The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Radiotherapy-Related Lymphopenia Affects Overall Survival in Patients With Lung Cancer
Open accessAbstract
INTRODUCTION Lymphopenia following radiotherapy has an adverse effect on patient's outcome. However, the relationship between radiotherapy dose delivery and lymphopenia is not fully understood. This work is utilizing image-based data mining to identify anatomical regions where the received dose is correlated with severe lymphopenia. METHODS 901 lung cancer patients were analyzed. A Cox model was used to assess prognostic factors of overall survival (OS). Two matched groups were defined-patients with and without lymphopenia≥G3-based on tumor volume, baseline lymphocytes, and delivered dose. Then, data mining was used to identify regions where dose correlates significantly with lymphopenia≥G3. For this, dose matrices were aligned using registration of the computed tomography (CT) images to one reference patient. Mean dose distributions were obtained for the two groups and organs of significance were detected. Dosimetric parameters from the identified organs that had the highest correlation with lymphocytes at nadir were selected. Multivariable analysis was conducted for lymphopenia≥G3 on the full lung cohort and the model was tested on 305 esophageal cancer patients. RESULTS Adjusted Cox regression showed that lymphopenia≥G3 was an independent factor of OS. The anatomical regions identified were heart, lung, and thoracic vertebrae. Dosimetric parameters for lymphopenia included vertebrae V20, mean lung dose and, mean heart dose which was further validated in the esophageal cancer cohort. CONCLUSIONS We have shown severe lymphopenia during radiotherapy is a significant poor prognostic factor for OS in lung cancer patients and could be mitigated by minimizing vertebrae V20, mean lung and heart dose to limit irradiation of stem cells and blood pool.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer
Antonia, S. J., Villegas, A., Daniel, D., Vicente, D., Murakami, S., Hui, R., Yokoi, T., Chiappori, A., Lee, K. H., de Wit, M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709937 · Cited by 4,593
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Antonia, S. J., Villegas, A., Daniel, D., Vicente, D., Murakami, S., Hui, R., Kurata, T., Chiappori, A., Lee, K. H., de Wit, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1809697 · Cited by 2,798
Cited by
Cardiac Toxicity of Thoracic Radiotherapy: Existing Evidence and Future Directions
Banfill, K., Giuliani, M., Aznar, M., Franks, K., McWilliam, A., Schmitt, M., Sun, F., Vozenin, M. C., & Faivre Finn, C. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.11.002 · Cited by 272
Self-citation
Metadata
- Authors
- Abravan, A., Faivre-Finn, C., Kennedy, J., McWilliam, A., & van Herk, M.
- Venue
- Journal of Thoracic Oncology
- Publisher
- Elsevier BV
- Published
- 2020-10
- Volume
- 15
- Issue
- 10
- Pages
- 1624-1635
- ISSN
- 1556-0864 (ISSN-L)
- OpenAlex
- W2944989507
- Cited by
- 183
- References
- 4
- FWCI
- 15.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.